📰 Rite Aid's Continued Struggles

In partnership with

Tired of Feeling Tired?

Your doctor says you’re fine. Your body says otherwise.

Welcome to Superpower, the 10x better annual checkup.

100+ lab tests (not the usual 15)
Tracking for life (not a one off snapshot)
24/7 Concierge team (not google)

It’s your health. Own it for $499.

Join today

Once a household name in the pharmacy world, Rite Aid is navigating yet another chapter in its long and turbulent story — and not the kind its executives were hoping for.

The Pennsylvania-based company, founded more than 60 years ago, was still generating over $24 billion in revenue as recently as 2023. But behind the numbers, a mix of industry pressures and internal challenges was steadily eroding its foundation.

Like many legacy drugstore chains, Rite Aid has faced shrinking margins on prescription reimbursements, rising wages, and declining sales of non-pharmacy items — think cosmetics, snacks, and seasonal goods — which have taken a hit from online competition (hello, Amazon) and retail powerhouses like Walmart.

To make matters worse, the company has been burdened with inflexible long-term leases that made closing underperforming stores difficult. And then there’s the legal fallout from opioid-related lawsuits — a heavy financial weight that’s cost millions in settlements.

In 2023, the company filed for Chapter 11 bankruptcy to cut down nearly $4 billion in debt and restructure for a more sustainable future. By late that year, Rite Aid emerged from bankruptcy as a private company with fewer stores, a new CEO, and a slimmer balance sheet. But the turnaround didn’t stick.

Earlier this month, Rite Aid filed for bankruptcy again, citing unexpected liquidity shortfalls fueled by lower-than-expected prescription activity and rising supply chain costs.

📦 Selling Off the Pieces

To pay down its obligations, Rite Aid has begun liquidating assets — including valuable prescription files. These files, which contain customers’ medication records, are highly sought after by competitors looking to grow in key markets.

CVS has reportedly purchased hundreds of these files to expand in areas where it already operates stores. Walgreens is also in the mix, bidding on select urban locations, according to court documents. The full financial details haven’t been disclosed yet, but updates are expected after a court hearing on May 21, 2025.

While sales are pending court and regulatory approvals, Rite Aid says stores will stay open during the transition to ensure customers continue receiving care.

🗣️ “We are working diligently to ensure our customers continue to receive quality care and our employees have opportunities to thrive during this transition,” said CEO Matt Schroeder.

Quick Facts:

• 📉 Employee count has dropped from 50,000 in 2020 to around 30,000 today.

• 🖥️ Rite Aid invested in telehealth, but adoption has been slower than expected.

• 💳 The wellness+ loyalty program has been scaled back, cutting back on rewards and discounts.

• 🛠️ Aging pharmacy tech has contributed to inefficiencies compared to competitors.

📬 Stay tuned for more updates after the May 21 hearing, and we’ll keep you informed on what this means for the pharmacy landscape — and for consumers like you.